Search

everythinglearnresearchcommunity

for

Search:↓

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

Pharmacist-led care significantly improved post-COVID symptoms.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Females are more likely than males to experience long-COVID symptoms and heart issues.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Aesthetic medicine needs clear ethical guidelines to ensure patient well-being and safety.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

A woman's complete hair loss condition improved after recovering from COVID-19.

COVID-19 pandemic increased alopecia areata cases and hospitalizations.

Fibroblast growth factors could be a better, safer treatment for hair loss than current options.

Many COVID-19 survivors, especially women, experience hair loss and skin color changes, needing specific post-recovery care.

Teledermatology is crucial and effective for remote skin care in India.

Five FDA-approved drugs may help block COVID-19 virus entry.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Exosomes from different stem cell sources affect immune cells and brain cell growth differently.

Adipose-derived stem cells show promise in treatments but need more research for safety, especially in cancer.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Hydroxychloroquine effectively treated a woman's lupus skin issues and hair loss.

The study found that in Eclipta prostrata roots, coumestans come from acetate and shikimate pathways, and phenylpropanoid is made only through the shikimate pathway.

Polygonum multiflorum may help treat hair loss but can be toxic to the liver.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Human hair follicle stem cells help repair tendon injuries.